News Select Year All Years 2026 (21) 2025 (37) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (21) BRACELET-1 (10) GOBLET (35) Search … November 3, 2009 Oncolytics Biotech(R) Inc. Announces Results of Second Warrant Expiry Date Acceleration Program November 2, 2009 Media Advisory – Oncolytics Biotech(R) Inc. to Present at BIO-Europe 2009 October 30, 2009 Oncolytics Biotech(R) Inc. Collaborators to Present Phase II Sarcoma Trial Results at CTOS Annual Meeting October 27, 2009 Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent October 26, 2009 Oncolytics Biotech(R) Inc. Announces Results of First Warrant Expiry Date Acceleration Program October 23, 2009 Media Advisory – Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009 October 20, 2009 Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company October 7, 2009 Media Advisory – Oncolytics Biotech(R) Inc. to Present at BioPartnering Europe October 2, 2009 Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers October 2, 2009 Oncolytics Biotech(R) Inc. Accelerates Warrant Expiry Date Newer Page 58 of 71 Older